Publications
281
Citations
12,586
Est. group size
—
Recurring co-author estimate
Active years
60
Publishing since 1967
Robert J. Lee's research investigates how taste receptors, particularly bitter taste receptors found outside the tongue, function in tissues like the nose, sinuses, and cancer cells. His work explores how activating these receptors can trigger cell death in cancers such as head and neck, thyroid, and lung cancer, as well as how they contribute to antibacterial defenses and mitochondrial function in respiratory tissues. This research bridges sensory biology, cancer biology, and infection/immune responses in the airway.
Publication output has fluctuated over the past decade with a notable peak in 2023, but has remained fairly steady overall, averaging about 14 publications per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Supplementary Figure 3 from T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma
2026
- Supplementary Figure 7 from T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma
2026
- Supplementary Figure 1 from T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma
2026
- Cigarette Smoke Exposure Attenuates <scp>T2R</scp> ‐Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma
Head & Neck · 2026
- Bitter Taste Receptor Agonists Induce Apoptosis in Papillary Thyroid Cancer
Head & Neck · 2025
- A deadly taste: linking bitter taste receptors and apoptosis
APOPTOSIS · 2025
- A dual-responsive metal-polyphenol nanomedicine based on targeting LAT1 via levodopa and ROS amplification for precise treatment of breast cancer
Free Radical Biology and Medicine · 2025
- Quercetin as a Bitter Taste Receptor Agonist with Anticancer Effects in Head and Neck Cancer Cells
Nutrients · 2025
- Quercetin as a Bitter Taste Receptor Agonist with Anticancer Effects in Head and Neck Cancer Cells
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- T2R5 agonist phendione decreases cell viability and induces apoptosis in head and neck squamous cell carcinoma
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Novel potent and selective fourth-generation inhibitors targeting EGFR for NSCLC therapy.
Journal of Clinical Oncology · 2025
- Targeted treatment for neuroblastoma using methoxyestradiol (2-ME)-loaded mitochondria-targeting immunoliposomes modified by datuximab (anti-GD2) and (L-cyclohexyl alanine-D-arginine)3 ((Fx,r)3) peptide
Cancer Nanotechnology · 2025
- T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma
Molecular Cancer Therapeutics · 2025
- Mechanisms of Mitochondrial Toxicity and Cytotoxicity Caused by <i>Pseudomonas aeruginosa</i> Pyocyanin in Human Nasal Epithelial Cells
International Forum of Allergy & Rhinology · 2025
- GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cells
Cell Death Discovery · 2024
- bioRxiv (Cold Spring Harbor Laboratory)×17
- International Forum of Allergy & Rhinology×7
- Nutrients×5
- American Journal of Orthodontics and Dentofacial Orthopedics×4
- Scientific Reports×4
- Cordelia A. Running
Nursing · Purdue University West Lafayette
- Susan P. Travers
Nursing · The Ohio State University
- Eunjin Cheon
Nursing · Purdue University West Lafayette
- Richard D. Mattes
Nursing · Purdue University West Lafayette
- B. Kalyanasundar
Nursing · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile